Indiana | 1-5672 | 13-5158950 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
1133 Westchester Avenue White Plains, New York |
10604 | |
(Address of principal executive offices) | (Zip Code) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
ITEM 2.01 | Completion of Acquisition or Disposition of Assets. |
ITEM 9.01 | Financial Statements and Exhibits. |
Exhibit | ||
No. | Description | |
3.1
|
Articles of Amendment of the Articles of Incorporation of ITT Corporation | |
99.1
|
Press release issued October 31, 2011 by ITT Corporation | |
99.2
|
Unaudited pro forma consolidated condensed income statements of ITT Corporation for the nine months ended September 30, 2011 and each of the three years ended December 31, 2010, 2009 and 2008 and unaudited pro forma consolidated balance sheet of ITT Corporation dated as of September 30, 2011 | |
99.3
|
Unaudited supplemental financial information updating the presentation from the Companys investor day on October 13, 2011 |
1
ITT CORPORATION |
||||
Date: November 4, 2011 | By: | /s/ Burt M. Fealing | ||
Burt M. Fealing |
Its: | Senior Vice President, General Counsel and Secretary | |||
(Authorized Officer of Registrant) | ||||
2
Exhibit | ||
No. | Description | |
3.1
|
Articles of Amendment of the Articles of Incorporation of ITT Corporation | |
99.1
|
Press release issued October 31, 2011 by ITT Corporation | |
99.2
|
Unaudited pro forma consolidated condensed income statements of ITT Corporation for the nine months ended September 30, 2011 and each of the three years ended December 31, 2010, 2009 and 2008 and unaudited pro forma consolidated balance sheet of ITT Corporation dated as of September 30, 2011 | |
99.3
|
Unaudited supplemental financial information updating the presentation from the Companys investor day on October 13, 2011 |
3
2
ITT Corporation | ||||||
By: | /s/ Burt M. Fealing
|
|||||
Name: | Burt M. Fealing | |||||
Title: | Senior Vice President, General Counsel & Secretary |
3
ITT Corporation 1133 Westchester Ave. White Plains, NY 10604 tel 914 641 2000 |
Investors: | Media: | ||
Melissa Trombetta | Kathleen Bark | ||
+1 914-641-2032 | +1 914-641-2103 | ||
melissa.trombetta@itt.com | kathleen.bark@itt.com |
2
| the Distribution through a tax-free dividend for U.S. shareholders and other adjustments resulting from the Spin-off; | ||
| the transfer, upon the Spin-off, of certain assets and liabilities by ITT to Exelis and Xylem. These assets and liabilities relate primarily to postretirement benefit plans for which Exelis and Xylem became the plans sponsors upon completion of the Spin-off; | ||
| the post-separation capital structure of ITT, including (i) the 1:2 Reverse Stock Split, (ii) the receipt of net contributions by Exelis and Xylem to ITT of $104 million and $555 million, respectively, and (iii) the retirement of $1.3 billion of indebtedness of ITT; and | ||
| the impact of, and transactions contemplated by, a Tax Matters Agreement dated October 25, 2011, among ITT, Exelis and Xylem and the provisions contained therein. |
2
Distribution of | ||||||||||||||||||||
Defense and | ||||||||||||||||||||
Distribution of | Information | |||||||||||||||||||
water-related | Solutions | Other | Pro forma for the | |||||||||||||||||
(in millions, except per share amounts) | Historical | businesses (a) | segment (a) | adjustments | Spin-off | |||||||||||||||
Revenue |
$ | 8,765 | $ | (2,791 | ) | $ | (4,373 | ) | $ | 10 | (b) | $ | 1,611 | |||||||
Costs of revenue |
6,286 | (1,710 | ) | (3,477 | ) | 7 | (b) | 1,106 | ||||||||||||
Gross profit |
2,479 | (1,081 | ) | (896 | ) | 3 | 505 | |||||||||||||
Selling, general and administrative expenses |
1,304 | (638 | ) | (395 | ) | | 271 | |||||||||||||
Research and development expenses |
195 | (73 | ) | (72 | ) | | 50 | |||||||||||||
Transformation costs |
279 | (67 | ) | (23 | ) | (189) | (c) | | ||||||||||||
Asbestos-related costs, net |
91 | | | | 91 | |||||||||||||||
Restructuring and asset impairment charges, net |
10 | (3 | ) | (5 | ) | | 2 | |||||||||||||
Operating income |
600 | (300 | ) | (401 | ) | 192 | 91 | |||||||||||||
Interest and non-operating expenses, net |
51 | 2 | 12 | (61) | (d) | 4 | ||||||||||||||
Income from continuing operations before
income tax expense |
549 | (302 | ) | (413 | ) | 253 | 87 | |||||||||||||
Income tax expense |
184 | (83 | ) | (150 | ) | 82 | (e) | 33 | ||||||||||||
Income from continuing operations |
$ | 365 | $ | (219 | ) | $ | (263 | ) | $ | 171 | $ | 54 | ||||||||
Basic earnings per share: |
$ | 0.59 | (i) | |||||||||||||||||
Diluted earnings per share: |
$ | 0.58 | (i) | |||||||||||||||||
Weighted average number of shares outstanding: |
||||||||||||||||||||
Basic |
92.3 | (i) | ||||||||||||||||||
Diluted |
92.7 | (i) |
3
Distribution of | ||||||||||||||||||||
Defense and | ||||||||||||||||||||
Distribution of | Information | |||||||||||||||||||
water-related | Solutions | Other | Pro forma for the | |||||||||||||||||
(in millions, except per share amounts) | Historical | businesses (a) | segment (a) | adjustments | Spin-off | |||||||||||||||
Revenue |
$ | 10,995 | $ | (3,192 | ) | $ | (5,895 | ) | $ | 16 | (b) | $ | 1,924 | |||||||
Costs of revenue |
7,820 | (1,990 | ) | (4,529 | ) | 11 | (b) | 1,312 | ||||||||||||
Gross profit |
3,175 | (1,202 | ) | (1,366 | ) | 5 | 612 | |||||||||||||
Selling, general and administrative expenses |
1,584 | (728 | ) | (505 | ) | (2) | (c) | 349 | ||||||||||||
Research and development expenses |
253 | (74 | ) | (119 | ) | | 60 | |||||||||||||
Asbestos-related costs, net |
385 | | | | 385 | |||||||||||||||
Restructuring and asset impairment charges, net |
53 | (15 | ) | (35 | ) | | 3 | |||||||||||||
Operating income |
900 | (385 | ) | (707 | ) | 7 | (185 | ) | ||||||||||||
Interest and non-operating expenses, net |
82 | 1 | 8 | (88) | (d) | 3 | ||||||||||||||
Income (loss) from continuing operations before
income tax expense |
818 | (386 | ) | (715 | ) | 95 | (188 | ) | ||||||||||||
Income tax expense (benefit) |
164 | (59 | ) | (250 | ) | 37 | (e) | (108 | ) | |||||||||||
Income (loss) from continuing operations |
$ | 654 | $ | (327 | ) | $ | (465 | ) | $ | 58 | $ | (80 | ) | |||||||
Basic loss per share: |
$ | (0.87 | )(i) | |||||||||||||||||
Diluted loss per share: |
$ | (0.87 | )(i),(j) | |||||||||||||||||
Weighted average number of shares outstanding: |
||||||||||||||||||||
Basic |
91.5 | (i) | ||||||||||||||||||
Diluted |
91.5 | (i),(j) |
4
Distribution of | ||||||||||||||||||||
Defense and | ||||||||||||||||||||
Distribution of | Information | |||||||||||||||||||
water-related | Solutions | Other | Pro forma for the | |||||||||||||||||
(in millions, except per share amounts) | Historical | businesses (a) | segment (a) | adjustments | Spin-off | |||||||||||||||
Revenue |
$ | 10,674 | $ | (2,839 | ) | $ | (6,064 | ) | $ | 18 | (b) | $ | 1,789 | |||||||
Costs of revenue |
7,650 | (1,808 | ) | (4,634 | ) | 12 | (b) | 1,220 | ||||||||||||
Gross profit |
3,024 | (1,031 | ) | (1,430 | ) | 6 | 569 | |||||||||||||
Selling, general and administrative expenses |
1,555 | (646 | ) | (555 | ) | | 354 | |||||||||||||
Research and development expenses |
258 | (63 | ) | (142 | ) | | 53 | |||||||||||||
Asbestos-related costs, net |
238 | | | | 238 | |||||||||||||||
Restructuring and asset impairment charges, net |
79 | (31 | ) | (5 | ) | | 43 | |||||||||||||
Operating income |
894 | (291 | ) | (728 | ) | 6 | (119 | ) | ||||||||||||
Interest and non-operating expenses, net |
84 | 1 | (2 | ) | (90) | (d) | (7 | ) | ||||||||||||
Income (loss) from continuing operations before
income tax expense |
810 | (292 | ) | (726 | ) | 96 | (112 | ) | ||||||||||||
Income tax expense (benefit) |
169 | (16 | ) | (253 | ) | 37 | (e) | (63 | ) | |||||||||||
Income (loss) from continuing operations |
$ | 641 | $ | (276 | ) | $ | (473 | ) | $ | 59 | $ | (49 | ) | |||||||
Basic loss per share: |
$ | (0.54 | )(i) | |||||||||||||||||
Diluted loss per share: |
$ | (0.54 | )(i),(j) | |||||||||||||||||
Weighted average number of shares outstanding: |
||||||||||||||||||||
Basic |
90.9 | (i) | ||||||||||||||||||
Diluted |
90.9 | (i),(j) |
5
Distribution of | ||||||||||||||||||||
Defense and | ||||||||||||||||||||
Distribution of | Information | |||||||||||||||||||
water-related | Solutions | Other | Pro forma for the | |||||||||||||||||
(in millions, except per share amounts) | Historical | businesses (a) | segment (a) | adjustments | Spin-off | |||||||||||||||
Revenue |
$ | 11,476 | $ | (3,281 | ) | $ | (6,063 | ) | $ | 19 | (b) | $ | 2,151 | |||||||
Costs of revenue |
8,262 | (2,149 | ) | (4,684 | ) | 13 | (b) | 1,442 | ||||||||||||
Gross profit |
3,214 | (1,132 | ) | (1,379 | ) | 6 | 709 | |||||||||||||
Selling, general and administrative expenses |
1,689 | (707 | ) | (583 | ) | | 399 | |||||||||||||
Research and development expenses |
236 | (64 | ) | (111 | ) | | 61 | |||||||||||||
Asbestos-related costs, net |
14 | | | | 14 | |||||||||||||||
Restructuring and asset impairment charges, net |
77 | (41 | ) | (13 | ) | | 23 | |||||||||||||
Operating income |
1,198 | (320 | ) | (672 | ) | 6 | 212 | |||||||||||||
Interest and non-operating expenses, net |
122 | (3 | ) | 7 | (111) | (d) | 15 | |||||||||||||
Income from continuing operations before income
tax expense |
1,076 | (317 | ) | (679 | ) | 117 | 197 | |||||||||||||
Income tax expense |
308 | (88 | ) | (233 | ) | 45 | (e) | 32 | ||||||||||||
Income from continuing operations |
$ | 768 | $ | (229 | ) | $ | (446 | ) | $ | 72 | $ | 165 | ||||||||
Basic earnings per share: |
$ | 1.82 | (i) | |||||||||||||||||
Diluted earnings per share: |
$ | 1.80 | (i) | |||||||||||||||||
Weighted average number of shares outstanding: |
||||||||||||||||||||
Basic |
90.7 | (i) | ||||||||||||||||||
Diluted |
91.6 | (i) |
6
Distribution of | ||||||||||||||||||||
Defense and | ||||||||||||||||||||
Distribution of | Information | |||||||||||||||||||
water-related | Solutions | Other | Pro forma for the | |||||||||||||||||
(in millions) | Historical | businesses (a) | segment (a) | adjustments | Spin-off | |||||||||||||||
Assets |
||||||||||||||||||||
Current assets: |
||||||||||||||||||||
Cash and cash equivalents |
$ | 2,686 | $ | (755 | ) | $ | (64 | ) | $ | (1,606) | (f) | $ | 920 | |||||||
659 | (g) | |||||||||||||||||||
Receivables, net |
2,198 | (753 | ) | (1,047 | ) | | 398 | |||||||||||||
Inventories, net |
1,011 | (436 | ) | (310 | ) | | 265 | |||||||||||||
Other current assets |
652 | (154 | ) | (173 | ) | 19 | (h),(f) | 344 | ||||||||||||
Total current assets |
6,547 | (2,098 | ) | (1,594 | ) | (928 | ) | 1,927 | ||||||||||||
Plant, property and equipment, net |
1,214 | (451 | ) | (466 | ) | | 297 | |||||||||||||
Goodwill |
4,471 | (1,787 | ) | (2,154 | ) | | 530 | |||||||||||||
Other intangible assets, net |
829 | (519 | ) | (224 | ) | | 86 | |||||||||||||
Asbestos-related assets |
819 | | | | 819 | |||||||||||||||
Other non-current assets |
1,208 | (129 | ) | (606 | ) | 18 | (h) | 491 | ||||||||||||
Total non-current assets |
8,541 | (2,886 | ) | (3,450 | ) | 18 | 2,223 | |||||||||||||
Total assets |
$ | 15,088 | $ | (4,984 | ) | $ | (5,044 | ) | $ | (910 | ) | $ | 4,150 | |||||||
Liabilities and Equity |
||||||||||||||||||||
Current liabilities: |
||||||||||||||||||||
Accounts payable |
$ | 1,116 | $ | (293 | ) | $ | (430 | ) | $ | | $ | 393 | ||||||||
Accrued and other current liabilities |
1,755 | (405 | ) | (830 | ) | (7 | )(f),(h) | 513 | ||||||||||||
Short-term borrowings and current
maturities of long-term debt |
1,305 | (5 | ) | | (1,288 | )(f) | 12 | |||||||||||||
Total current liabilities |
4,176 | (703 | ) | (1,260 | ) | (1,295 | ) | 918 | ||||||||||||
Postretirement benefits |
2,658 | (249 | ) | (2,149 | ) | | 260 | |||||||||||||
Long-term debt |
1,868 | (1,202 | ) | (662 | ) | | 4 | |||||||||||||
Asbestos-related liabilities |
1,522 | | | | 1,522 | |||||||||||||||
Other non-current liabilities |
619 | (222 | ) | (113 | ) | 33 | (h) | 317 | ||||||||||||
Total non-current liabilities |
6,667 | (1,673 | ) | (2,924 | ) | 33 | 2,103 | |||||||||||||
Total liabilities |
10,843 | (2,376 | ) | (4,184 | ) | (1,262 | ) | 3,021 | ||||||||||||
Shareholders Equity: |
||||||||||||||||||||
Common stock |
185 | | | (92 | )(i) | 93 | ||||||||||||||
Retained earnings |
5,709 | (2,586 | ) | (2,569 | ) | 444 | 998 | |||||||||||||
Total accumulated other comprehensive
(loss) income |
(1,649 | ) | (22 | ) | 1,709 | | 38 | |||||||||||||
Total shareholders equity |
4,245 | (2,608 | ) | (860 | ) | 352 | 1,129 | |||||||||||||
Total liabilities and shareholders equity |
$ | 15,088 | $ | (4,984 | ) | $ | (5,044 | ) | $ | (910 | ) | $ | 4,150 | |||||||
7
(a) | Reflects the operations, assets, liabilities and equity of Exelis Inc. (Exelis), formerly ITTs Defense and Information Solutions segment, and Xylem Inc. (Xylem), formerly ITTs water-related businesses, the issued and outstanding shares of common stock of which were distributed by way of a distribution (the Distribution) on October 31, 2011 (the Distribution Date) on a pro rata basis, to ITT shareholders of record on October 17, 2011 (the Spin-off). Additionally, balance sheet amounts reflect the impact of other assets and liabilities that were contributed to Exelis and Xylem by ITT, primarily related to postretirement benefit plans and associated deferred tax positions. On the Distribution Date, ITT transferred to Exelis and Xylem certain defined benefit pension and other postretirement benefit plans. Most significantly, the ITT Salaried Retirement Plan was transferred to Exelis. Exelis and Xylem assumed all assets and liabilities associated with the plans contributed to them and became the plans sponsor on the Distribution Date. Excluded from these amounts are certain general corporate overhead expenses not specifically related to Exelis or Xylem. Such general corporate overhead expenses do not meet the requirements to be presented in discontinued operations and thus, will be presented as part of ITTs continuing operations. | |
(b) | Reflects the effects of intercompany sales from us to Exelis and Xylem that will be reflected as third party transactions subsequent to the Distribution. | |
(c) | Reflects the removal of transformation costs directly related to the Spin-off that were incurred during the historical period. These costs were primarily for tax, information technology, advisory fees, and other costs in addition to a non-cash impairment charge related to a decision to discontinue development of an information technology consolidation initiative. | |
(d) | Reflects a reduction of the actual interest expense incurred in connection with debt securities retired by ITT in October 2011 as part of ITTs post-separation capital structure. See note (f) for additional details. | |
(e) | Adjusted to reflect the income tax effects of the pro forma adjustments at the applicable statutory tax rates, except for the removal of transformation costs which reflect historical tax rates. | |
(f) | Reflects the retirement of certain of ITTs outstanding debt securities, including related interest rate swaps, debt issuance costs and costs to retire the debt securities. During October 2011, ITT extinguished $1,250 million of long-term debt in advance of maturity, consisting of $500 million of 4.9% senior unsecured notes due May 1, 2014, $500 million of 6.125% senior unsecured notes due May 1, 2019, and $250 million of 7.4% senior unsecured notes due November 15, 2025. These transactions resulted in a pre-tax charge of approximately $291 million. | |
(g) | Reflects the net contributions immediately prior to the Distribution by Exelis to ITT of $104 million, using the proceeds from their issuance of debt securities of $240 million in October 2011, and by Xylem to ITT of $555 million, both pursuant to the terms of the Distribution Agreement. | |
(h) | Reflects adjustments to reclassify deferred income taxes retained by ITT due to the netting of deferred tax assets and deferred tax liabilities within a single tax jurisdiction. | |
(i) | Common stock and pro forma weighted-average basic and diluted shares outstanding reflect the effect of a one-for-two reverse stock split of ITT common stock. Additional share impacts as a result of the Spin-off have been excluded as they are not currently determinable. | |
(j) | The effects of certain previously dilutive securities are anti-dilutive for the years ended December 31, 2010 and 2009 on a pro forma basis. |
8
| Pro Forma Revenues are defined as reported GAAP revenues adjusted for the benefit of certain historical transactions between ITT and Exelis and Xylem that previously eliminated in consolidation. |
| Adjusted Segment Operating Income and Adjusted Segment Operating Margin are defined as GAAP Segment Operating Income and Operating Margin, adjusted for special items and pro forma adjustments. Special items represent significant charges or credits that impact current results, but may not be related to the Companys ongoing operations and performance. Pro forma adjustments reflect the benefit of certain historical transactions between ITT and Exelis and Xylem that previously eliminated in consolidation. |
| Adjusted Operating EBIT and Adjusted Operating EBIT Margin are defined as operating income and margin, adjusted for special items that may include, but are not limited to, non-operating items, transformation costs, and pro forma adjustments. Special items represent significant charges or credits that impact current results, but may not be related to the Companys ongoing operations and performance. Pro forma adjustments relate to certain historical transactions between ITT and Exelis and Xylem that previously eliminated in consolidation. |
| Adjusted EBITDA and Adjusted EBITDA Margin are defined as operating income and margin before depreciation, amortization and stock based compensation, adjusted for special items that may include, but are not limited to, non-operating items, transformation costs, and pro forma adjustments. Special items represent significant charges or credits that impact current results, but may not be related to the Companys ongoing operations and performance. Pro forma adjustments relate to certain historical transactions between ITT and Exelis and Xylem that previously eliminated in consolidation. |
Nine months | ||||||||||||||||
ended | ||||||||||||||||
September 30, | ||||||||||||||||
(in millions) | 2008 | 2009 | 2010 | 2011 | ||||||||||||
Revenue |
||||||||||||||||
Total Segment Revenues |
$ | 2,153 | $ | 1,794 | $ | 1,930 | $ | 1,616 | ||||||||
Less: Intercompany Eliminations |
(21 | ) | (23 | ) | (22 | ) | (15 | ) | ||||||||
Consolidated Revenue GAAP |
$ | 2,132 | $ | 1,771 | $ | 1,908 | $ | 1,601 | ||||||||
Adjustments |
||||||||||||||||
Pro Forma (a) |
19 | 18 | 16 | 10 | ||||||||||||
Pro Forma Consolidated Revenue |
$ | 2,151 | $ | 1,789 | $ | 1,924 | $ | 1,611 | ||||||||
Segment Operating Income |
||||||||||||||||
GAAP |
$ | 281 | $ | 171 | $ | 230 | $ | 221 | ||||||||
Adjustments |
||||||||||||||||
Restructuring and Realignment |
44 | 48 | 4 | 2 | ||||||||||||
Pro Forma (a) |
6 | 6 | 5 | 3 | ||||||||||||
Total Adjustments |
$ | 50 | $ | 54 | $ | 9 | $ | 5 | ||||||||
Adjusted Segment Operating Income |
$ | 331 | $ | 225 | $ | 239 | $ | 226 | ||||||||
Adjusted Segment Operating Margin |
15.4 | % | 12.6 | % | 12.4 | % | 14.0 | % |
(a) | Pro forma amounts reflect the benefit of transactions between ITT and Exelis and Xylem that previously eliminated in consolidation. |
2
Nine months | ||||||||||||||||
ended | ||||||||||||||||
September 30, | ||||||||||||||||
(in millions) | 2008 | 2009 | 2010 | 2011 | ||||||||||||
Total Adjusted Segment Operating Income |
$ | 331 | $ | 225 | $ | 239 | $ | 226 | ||||||||
Less Corporate Costs after Adjustments (a): |
||||||||||||||||
Corporate General and Administrative Expenses |
45 | 55 | 36 | 24 | ||||||||||||
Corporate Restructuring & Realignment |
(4 | ) | | | | |||||||||||
Corporate Transformation Costs |
| | | 10 | ||||||||||||
Information System Initiatives (b) |
| (1 | ) | (4 | ) | (4 | ) | |||||||||
Other Expenses |
16 | 3 | (1 | ) | 12 | |||||||||||
Adjusted Corporate Costs |
$ | 57 | $ | 57 | $ | 31 | $ | 42 | ||||||||
Adjusted Operating EBIT |
$ | 274 | $ | 168 | $ | 208 | $ | 184 | ||||||||
Adjusted Operating EBIT Margin |
12.7 | % | 9.4 | % | 10.8 | % | 11.4 | % |
Notes: |
||||||||||||||||
|
||||||||||||||||
(a) Corporate costs exclude the following: |
||||||||||||||||
Information System Initiatives (b) |
$ | | $ | | $ | | $ | 55 | ||||||||
Asbestos Remeasurement (c) |
$ | | $ | 210 | $ | 330 | $ | 41 | ||||||||
Asbestos Provision (d) |
$ | 14 | $ | 28 | $ | 55 | $ | 50 |
(b) | Information System initiatives which were terminated as a result of the Spin-off. | |
(c) | Effect of annual asbestos reassessment. | |
(d) | 2008 reflects adjustment related to pending claims. 2009, 2010 and nine months ended September 30, 2011 reflect the effect of maintaining rolling 10 year net asbestos liability. |
3
Nine months | ||||||||||||||||
ended | ||||||||||||||||
September 30, | ||||||||||||||||
(in millions) | 2008 | 2009 | 2010 | 2011 | ||||||||||||
GAAP Operating Income |
$ | 206 | $ | (125 | ) | $ | (192 | ) | $ | 19 | ||||||
Pro Forma
Adjustments |
||||||||||||||||
Pro Forma (a) |
6 | 6 | 5 | 3 | ||||||||||||
Transformation Costs |
| | 2 | 10 | ||||||||||||
Information
System Initiatives (b) |
| | | 59 | ||||||||||||
Pro Forma
Operating Income |
$ | 212 | $ | (119 | ) | $ | (185 | ) | $ | 91 | ||||||
Non GAAP
Adjustments |
||||||||||||||||
Restructuring and Realignment |
$ | 48 | $ | 48 | $ | 4 | $ | 2 | ||||||||
Information System Initiatives (b) |
| 1 | 4 | | ||||||||||||
Asbestos Remeasurement (c) |
| 210 | 330 | 41 | ||||||||||||
Asbestos Provision (d) |
14 | 28 | 55 | 50 | ||||||||||||
Total Asbestos Expense |
$ | 14 | $ | 238 | $ | 385 | $ | 91 | ||||||||
Total Adjustments |
$ | 62 | $ | 287 | $ | 393 | $ | 93 | ||||||||
Adjusted Operating EBIT |
$ | 274 | $ | 168 | $ | 208 | $ | 184 | ||||||||
Depreciation |
$ | 57 | $ | 54 | $ | 52 | $ | 42 | ||||||||
Amortization and Stock Based Compensation |
18 | 25 | 27 | 19 | ||||||||||||
Adjusted Operating EBITDA |
$ | 349 | $ | 247 | $ | 287 | $ | 245 | ||||||||
Adjusted Operating EBITDA Margin |
16.2 | % | 13.8 | % | 14.9 | % | 15.2 | % |
(a) | Pro forma amounts reflect the benefit of transactions between ITT and Exelis and Xylem that previously eliminated in consolidation. | |
(b) | Information System initiatives which were terminated as a result of the Spin-off. | |
(c) | Effect of annual asbestos reassessment. | |
(d) | 2008 reflects the adjustment related to pending claims. 2009, 2010 and nine months ended September 30, 2011 reflect the effect of maintaining rolling 10 year net asbestos liability. |
4
Nine months | ||||||||||||||||
ended | ||||||||||||||||
September 30, | ||||||||||||||||
(in millions) | 2008 | 2009 | 2010 | 2011 | ||||||||||||
Industrial Process Operating Income |
||||||||||||||||
GAAP Operating Income |
$ | 114 | $ | 72 | $ | 79 | $ | 77 | ||||||||
Adjustments |
||||||||||||||||
Restructuring and Realignment |
19 | 16 | 1 | | ||||||||||||
Pro Forma (a) |
3 | 4 | 3 | 2 | ||||||||||||
Total Adjustments |
$ | 22 | $ | 20 | $ | 4 | $ | 2 | ||||||||
Adjusted Operating Income |
$ | 136 | $ | 92 | $ | 83 | $ | 79 | ||||||||
Adjusted Operating Margin |
16.7 | % | 12.8 | % | 11.9 | % | 14.3 | % | ||||||||
Motion
Technologies Operating Income |
||||||||||||||||
GAAP Operating Income |
$ | 82 | $ | 48 | $ | 85 | $ | 67 | ||||||||
Adjustments |
||||||||||||||||
Restructuring and Realignment |
8 | 22 | | | ||||||||||||
Pro Forma (a) |
| | | | ||||||||||||
Total Adjustments |
$ | 8 | $ | 22 | $ | | $ | | ||||||||
Adjusted Operating Income |
$ | 90 | $ | 70 | $ | 85 | $ | 67 | ||||||||
Adjusted Operating Margin |
16.0 | % | 14.3 | % | 15.5 | % | 13.4 | % | ||||||||
Interconnect Solutions Operating Income |
||||||||||||||||
GAAP Operating Income |
$ | 42 | $ | 19 | $ | 37 | $ | 34 | ||||||||
Adjustments |
||||||||||||||||
Restructuring and Realignment |
8 | 7 | 1 | | ||||||||||||
Pro Forma (a) |
3 | 2 | 2 | 1 | ||||||||||||
Total Adjustments |
$ | 11 | $ | 9 | $ | 3 | $ | 1 | ||||||||
Adjusted Operating Income |
$ | 53 | $ | 28 | $ | 40 | $ | 35 | ||||||||
Adjusted Operating Margin |
11.7 | % | 8.2 | % | 9.8 | % | 10.9 | % | ||||||||
Control
Technologies Operating Income |
||||||||||||||||
GAAP Operating Income |
$ | 43 | $ | 32 | $ | 29 | $ | 43 | ||||||||
Adjustments |
||||||||||||||||
Restructuring and Realignment |
9 | 3 | 2 | 2 | ||||||||||||
Pro Forma (a) |
| | | | ||||||||||||
Total Adjustments |
$ | 9 | $ | 3 | $ | 2 | $ | 2 | ||||||||
Adjusted Operating Income |
$ | 52 | $ | 35 | $ | 31 | $ | 45 | ||||||||
Adjusted Operating Margin |
16.1 | % | 14.4 | % | 11.3 | % | 18.5 | % | ||||||||
(a) | Pro forma amounts reflect the benefit of transactions between ITT and Exelis and Xylem that previously eliminated in consolidation. |
5
Nine months | ||||||||||||||||
ended | ||||||||||||||||
September 30, | ||||||||||||||||
(in millions) | 2008 | 2009 | 2010 | 2011 | ||||||||||||
As Reported |
||||||||||||||||
Net Annual Asbestos Remeasurement (a) |
$ | | $ | 210 | $ | 330 | $ | 41 | ||||||||
Net Asbestos Provision (b) |
14 | 28 | 55 | 50 | ||||||||||||
Total Net Asbestos Expense |
$ | 14 | $ | 238 | $ | 385 | $ | 91 | ||||||||
Tax Effect |
||||||||||||||||
Net Annual Asbestos Remeasurement |
$ | | $ | 79 | $ | 118 | $ | 16 | ||||||||
Net Asbestos Provision |
5 | 11 | 20 | 19 | ||||||||||||
Total Net Asbestos Expense |
$ | 5 | $ | 90 | $ | 138 | $ | 35 | ||||||||
After-Tax Effect |
||||||||||||||||
Net Annual Asbestos Remeasurement |
$ | | $ | 131 | $ | 212 | $ | 25 | ||||||||
Net Asbestos Provision |
9 | 17 | 35 | 31 | ||||||||||||
Total Net Asbestos Expense |
$ | 9 | $ | 148 | $ | 247 | $ | 56 |
(a) | Effect of annual asbestos reassessment. | |
(b) | 2008 reflects the adjustment related to pending claims. 2009, 2010 and the nine months ended September 30, 2011 reflect the effect of maintaining rolling 10 year net asbestos liability. |
6